MKMrignayani Kotecha

Mrignayani Kotecha

*This is an algorithmically generated author record based on publicly available information.

Mrignayani Kotecha has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Advanced Inversion Recovery Single Point Imaging for High Spatial Resolution and Quantitative Oxygen Imaging

    by Boris Epel, Irene Canavesi, Mrignayani Kotecha

    Purpose: The partial pressure of oxygen (pO 2 ) in tissue is a tightly regulated physiological quantity. Hypoxia is a hallmark of many diseases, and changes in tissue pO 2 underline critical developmental, metabolic, and physiological processes. Electron paramagnetic resonance oxygen imaging (EPROI) has emerged as the most precise technique to image pO 2 in vitro and in vivo. EPROI uses linear relationship between the relaxation rates (R 1 or R 2 ) of the spin probe OXO71 and pO 2 . Methods: The current gold standard for EPROI is inversion recovery electron spin echo (IRESE) sequence with radial k ‐space acquisition scheme, which is fast, provides high pO 2 resolution using T 1 imaging, but suffers from low spatial resolution, especially at higher oxygen concentrations. The other method, single‐point imaging (SPI), which uses Cartesian k ‐space acquisition scheme and free‐induction decay (FID) readout, provides higher spatial resolution but has lower signal‐to‐noise ratio (SNR) and lower pO 2 accuracy, especially for T 2 * imaging. In this work, we introduce advanced inversion‐recovery single‐point imaging (AIR‐SPI), which combines inversion‐recovery SPI (IR‐SPI) with multi‐point FID averaging in the spatial domain. We evaluate the performance of AIR‐SPI in phantoms and in vivo imaging of a fibrosarcoma (FSA) tumor in a mouse leg. Results: We demonstrate 2–8‐fold SNR improvement and higher spatial resolution for AIR‐SPI compared to IR‐SPI and IRESE, especially for high oxygen concentrations. We also demonstrate higher pO 2 precision for AIR‐SPI. Conclusions: AIR‐SPI offers improvements in image SNR, spatial, and oxygen resolution over all existing EPR oxygen imaging methods, without increasing imaging time. Importantly, it uses smaller RF power than echo‐based methods, which is crucial for scaling EPROI to human applications.

  • Trityl OXO71 Pharmacokinetics and Distribution in Rhesus Macaques

    by Christopher D. Kroenke, Irene Canavesi, Jenna N. Castro, Joshua A. Karpf, Raman Khurana, Megan M. Holloway, Mitasha S. Palha, Eric A. Legenzov, Nathan P. Crilly, Boris Epel, et al.

    Purpose: Electron paramagnetic resonance oxygen imaging ( EPROI ) techniques have the ability to quantify the partial pressure of oxygen ( pO 2 ), in vivo, through quantitative measurement of T 1e maps of the trityl radical, OXO71 . OXO71 ‐based EPROI has seen several applications in small animal imaging studies, but translation to humans will benefit from optimization of EPROI using large animal subjects that are anatomically and physiologically similar to humans. The goal of this study was to characterize pharmacokinetics and tissue distribution following an intravenous administration of OXO71 in rhesus macaques. Methods: A 92 μmol/kg OXO71 dose, equivalent to doses used in studies with other animal species, was administered as a bolus injection over a 10‐min period in 3 animals. Plasma and urine were sampled over the subsequent 2 h. A second equivalent dose was then rapidly administered, animals were euthanized, and OXO71 distribution was assessed in harvested tissues by EPR imaging. Results: Pharmacokinetics of plasma OXO71 determined by EPR spectroscopy showed biphasic clearance, characterized by distinct initial and terminal half‐lives of 12.4 ± 1.2 min and 67.7 ± 8.9 min, respectively. Some variability in trityl concentration was observed between organs, but appreciable concentration was found for all tissues except the brain. Conclusion: No adverse physiological effects of the infusions were observed, consistent with a low toxicity of OXO71. These findings indicate EPROI using OXO71 is safe in primates, and provide information related to the dose and time constraints for performing EPROI in other large animal species including humans.


  • Accelerated EPR imaging using deep learning denoising

    by Irene Canavesi, Navin Viswakarma, Boris Epel, Alan McMillan, Mrignayani Kotecha

    Purpose: Trityl OXO71‐based pulse electron paramagnetic resonance imaging (EPRI) is an excellent technique to obtain partial pressure of oxygen (pO 2 ) maps in tissues. In this study, we used deep learning techniques to denoise 3D EPR amplitude and pO 2 maps. Methods: All experiments were performed using a 25 mT EPR imager, JIVA‐25®. The MONAI implementation of four neural networks (autoencoder, Attention UNet, UNETR, and UNet) was tested, and the best model (UNet) was then enhanced with joint bilateral filters (JBF). The training dataset was comprised of 227 3D images (56 in vivo and 171 in vitro), 159 images for training, 45 for validation, and 23 for testing. UNet with 1, 2, and 3 JBF layers was tested to improve image SNR, focusing on multiscale structural similarity index measure and edge sensitivity preservation. The trained algorithm was tested using acquisitions with 15, 30, and 150 averages in vitro with a sealed deoxygenated OXO71 phantom and in vivo with fibrosarcoma tumors grown in a hind leg of C3H mice. Results: We demonstrate that UNet with 2 JBF layers (UNet+JBF2) provides the best outcome. We demonstrate that using the UNet+JBF2 model, the SNR of 15‐shot amplitude maps provides higher SNR compared to 150‐shot pre‐filter maps, both in phantoms and in tumors, therefore, allowing 10‐fold accelerated imaging. We demonstrate that the trained algorithm improves SNR in pO 2 maps. Conclusions: We demonstrate the application of deep learning techniques to EPRI denoising. Higher SNR will bring the EPRI technique one step closer to clinics.


  • Composite spin probes with adjustable oxygen sensitivity for pulse electron paramagnetic resonance imaging

    by Irene Canavesi, Navin Viswakarma, Raman Khurana, Boris Epel, Periannan Kuppusamy, Mark David Pagel, Mrignayani Kotecha

    Purpose: Solid crystalline spin probes, such as lithium phthalocyanine (LiPc) and lithium octa‐n‐butoxynaphthalocyanine (LiNc‐BuO), allow repeated oxygen measurement using electron paramagnetic resonance (EPR). Due to their short relaxation times, their use for pulse EPR oxygen imaging is limited. In this study, we developed and tested a new class of solid composite spin probes that modified the relaxation rates R1 and R2 of LiPc or LiNc‐BuO probes, which allowed pO2 measurements in the full dynamic (0–760 torr) range.Methods: The composite probes were developed by embedding LiPc or LiNc‐BuO with bonewax, beeswax, or petroleum jelly. All experiments were performed using a 25‐mT EPR imager, JIVA‐25®. A selected composite probe, LiPc‐BW5 (LiPc + 5‐times bonewax), was tested for its in vivo stability and robustness using oxygen‐enhanced EPR oxygen imaging. As another application, a LiPc‐BW5‐based marker was tested to outline the SCC7 tumor in a C3H mouse.Results: The composite probes showed an increased oxygen measurement range compared with unaltered probes. The in vivo experiments with LiPc‐BW5 showed the stability of the probes for repeated oxygen imaging up to 4 weeks of measurements. The in vivo pO2 at the subcutaneous site changed from 26.1 ± 1.9 torr to 118.9 ± 1.9 torr when the breathing gas was changed from 21% O2 to 100% O2. The use of LiPc‐BW5 as a fiducial marker showed its use in outlining the tumor boundaries.Conclusions: We developed a new class of robust and versatile solid composite probes with adjustable oxygen sensitivity that allows pO2 imaging in the broad dynamic range.


  • In Vivo Mouse Abdominal Oxygen Imaging And Assessment of Subcutaneously Implanted Beta Cell Replacement Devices

    by Irene Canavesi, Navin Viswakarma, Boris Epel, Mrignayani Kotecha

    Purpose Type 1 diabetes (T1D) is an autoimmune disease that leads to the loss of insulin-producing pancreatic beta cells. Beta cell replacement devices or bioartificial pancreas (BAP) have shown promise in curing T1D and providing long-term insulin independence without the need for immunosuppressants. Hypoxia in BAP devices damages cells and imposes limitations on device dimensions. Noninvasive in vivo oxygen imaging assessment of implanted BAP devices will provide the necessary feedback and improve the chances of success. Pulse-mode electron paramagnetic resonance (EPR) oxygen imaging (EPROI) using injectable trityl OX071 as the oxygen-sensitive agent is an excellent technique for obtaining partial oxygen pressure (pO2) maps in vitro and in vivo. In this study, our goal was to optimize in vivo mouse abdominal EPROI and demonstrate proof-of-concept pO2 imaging of subcutaneously implanted BAP devices. Methods All EPROI experiments were performed using a 25 mT EPROI instrument, JIVA-25®. For in vivo EPROI experiments, trityl OX071, a whole-body mouse resonator (∅32 mm × 35 mm), C57BL6 mice, and the inversion recovery electron spin echo (IRESE) pulse sequence were utilized. We investigated the signal amplitude and pO2 in mouse abdomen region for intravenous (i.v.) and intraperitoneal (i.p.) injection methods with either only a single bolus (B) or bolus plus infusion (BI) for 72.2 mM OX071 and the effect of OX071 concentrations from 18 to 72.2 mM for the i.p.-B injection method. We also investigated the impact of animal respiratory rate on mouse abdominal pO2. Finally, we performed proof-of-concept pO2 imaging of two subcutaneously implanted BAP devices, OxySite and TheraCyte. At the end of the four-week study, the TheraCyte devices were extracted and analyzed for fibrosis, vascular differentiation, and immune cell infiltration. Results We established that mouse abdominal pO2 remains stable irrespective of trityl injection methods, concentrations, imaging time, or animal breathing rate. We demonstrate that the i.p.-B and i.p.-BI methods are suitable for EPROI, and i.p.-B method provides higher signal amplitude compared to i.v.-BI and up to 75 min of imaging. An injection with a reduced trityl concentration and higher volume provides higher signal amplitude for i.p.-B method at the beginning. We also highlight the advantage of milder anesthesia for consistent, reliable mouse pO2 imaging. Finally, we demonstrate that EPROI could provide longitudinal noninvasive oxygen assessment of subcutaneously implanted BAP devices in vivo. Conclusions In vivo EPROI is a reliable technique for mouse abdominal oxygen imaging and longitudinal assessment of subcutaneously implanted BAP devices noninvasively. This work reports abdominal oxygen imaging in the mouse model and demonstrates its application for the assessment of BAP devices. Even though the application focus of this work was on cell therapy, the techniques developed will have a much broader use in the biomedical field. Graphical Abstract


  • Open Access

    Author Correction: Nondestructive, longitudinal, 3D oxygen imaging of cells in a multi-well plate using pulse electron paramagnetic resonance imaging

    by Safa Hameed, Navin Viswakarma, Greta Babakhanova, Carl G. Simon, Boris Epel, Mrignayani Kotecha


  • Open Access

    Nondestructive, longitudinal, 3D oxygen imaging of cells in a multi-well plate using pulse electron paramagnetic resonance imaging

    by Safa Hameed, Navin Viswakarma, Greta Babakhanova, Carl G. Simon, Boris Epel, Mrignayani Kotecha

    The use of oxygen by cells is an essential aspect of cell metabolism and a reliable indicator of viable and functional cells. Here, we report partial pressure oxygen (pO2) mapping of live cells as a reliable indicator of viable and metabolically active cells. For pO2 imaging, we utilized trityl OX071-based pulse electron paramagnetic resonance oxygen imaging (EPROI), in combination with a 25 mT EPROI instrument, JIVA-25™, that provides 3D oxygen maps with high spatial, temporal, and pO2 resolution. To perform oxygen imaging in an environment-controlled apparatus, we developed a novel multi-well-plate incubator-resonator (MWIR) system that could accommodate 3 strips from a 96-well strip-well plate and image the middle 12 wells noninvasively and simultaneously. The MWIR system was able to keep a controlled environment (temperature at 37 °C, relative humidity between 70%–100%, and a controlled gas flow) during oxygen imaging and could keep cells alive for up to 24 h of measurement, providing a rare previously unseen longitudinal perspective of 3D cell metabolic activities. The robustness of MWIR was tested using an adherent cell line (HEK-293 cells), a nonadherent cell line (Jurkat cells), a cell-biomaterial construct (Jurkat cells seeded in a hydrogel), and a negative control (dead HEK-293 cells). For the first time, we demonstrated that oxygen concentration in a multi-well plate seeded with live cells reduces exponentially with the increase in cell seeding density, even if the cells are exposed to incubator-like gas conditions. For the first time, we demonstrate that 3D, longitudinal oxygen imaging can be used to assess cells seeded in a hydrogel. These results demonstrate that MWIR-based EPROI is a versatile and robust method that can be utilized to observe the cell metabolic activity nondestructively, longitudinally, and in 3D. This approach may be useful for characterizing cell therapies, tissue-engineered medical products, and other advanced therapeutics.


  • Assessment of blood–brain barrier leakage and brain oxygenation in Connexin‐32 knockout mice with systemic neuroinflammation using pulse electron paramagnetic resonance imaging techniques

    by Boris Epel, Navin Viswakarma, Safa Hameed, Mona M. Freidin, Charles K. Abrams, Mrignayani Kotecha

    Purpose: The determination of blood–brain barrier (BBB) integrity and partial pressure of oxygen (pO2) in the brain is of substantial interest in several neurological applications. This study aimed to assess the feasibility of using trityl OX071‐based pulse electron paramagnetic resonance imaging (pEPRI) to provide a quantitative estimate of BBB integrity and pO2 maps in mouse brains as a function of neuroinflammatory disease progression.Methods: Five Connexin‐32 (Cx32)–knockout (KO) mice were injected with lipopolysaccharide to induce neuroinflammation for imaging. Three wild‐type mice were also used to optimize the imaging procedure and as control animals. An additional seven Cx32‐KO mice were used to establish the BBB leakage of trityl using the colorimetric assay. All pEPRI experiments were performed using a preclinical instrument, JIVA‐25 (25 mT/720 MHz), at times t = 0, 4, and 6 h following lipopolysaccharide injection. Two pEPRI imaging techniques were used: (a) single‐point imaging for obtaining spatial maps to outline the brain and calculate BBB leakage using the signal amplitude, and (b) inversion‐recovery electron spin echo for obtaining pO2 maps.Results: A statistically significant change in BBB leakage was found using pEPRI with the progression of inflammation in Cx32 KO animals. However, the change in pO2 values with the progression of inflammation for these animals was not statistically significant.Conclusions: For the first time, we show the ability of pEPRI to provide pO2 maps in mouse brains noninvasively, along with a quantitative assessment of BBB leakage. We expect this study to open new queries from the field to explore the pathology of many neurological diseases and provide a path to new treatments.


  • SOX71, A Biocompatible Succinyl Derivative of the Triarylmethyl Radical OX071 for In Vivo Quantitative Oxygen Mapping Using Electron Paramagnetic Resonance

    by Misa A. Shaw, Martin Poncelet, Navin Viswakarma, Gian Paolo Vallerini, Safa Hameed, Teresa D. Gluth, Werner J. Geldenhuys, Emily H. Hoblitzell, Timothy D. Eubank, Boris Epel, et al.

    Purpose This study aimed to develop a biocompatible oximetric electron paramagnetic resonance (EPR) spin probe with reduced self-relaxation, and sensitivity to oxygen for a higher signal-to-noise ratio and longer relaxation times at high oxygen concentration, compared to the reference spin probe OX071. Procedures SOX71 was synthesized by succinylation of the twelve alcohol groups of OX071 spin probe and characterized by EPR at X-Band (9.5 GHz) and at low field (720 MHz). The biocompatibility of SOX71 was tested in vitro and in vivo in mice. A pharmacokinetic study was performed to determine the best time frame for EPR imaging. Finally, a proof-of-concept EPR oxygen imaging was performed on a mouse model of a fibrosarcoma tumor. Results SOX71 was synthesized in one step from OX071. SOX71 exhibits a narrow line EPR spectrum with a peak-to-peak linewidth of 66 mG, similar to OX071. SOX71 does not bind to albumin nor show cell toxicity for the concentrations tested up to 5 mM. No toxicity was observed after systemic delivery via intraperitoneal injection in mice at twice the dose required for EPR imaging. After the injection, the probe is readily absorbed into the bloodstream, with a peak blood concentration half an hour, post-injection. Then, the probe is quickly cleared by the kidney with a half-life of ~ 45 min. SOX71 shows long relaxation times under anoxic condition (T1e = 9.5 µs and T2e = 5.1 µs; [SOX71] = 1 mM in PBS at 37 °C, pO2 = 0 mmHg, 720 MHz). Both the relaxation rates R1e and R2e show a decreased sensitivity to pO2, leading to twice longer relaxation times under room air conditions (pO2 = 159 mmHg) compared to OX071. This is ideal for oxygen imaging in samples with a wide range of pO2. Both the relaxation rates R1e and R2e show a decreased sensitivity to self-relaxation compared to OX071, with a negligible effect of the probe concentration on R1e. SOX71 was successfully applied to image oxygen in a tumor. Conclusion SOX71, a succinylated derivative of OX071 was synthesized, characterized, and applied for in vivo EPR tumor oxygen imaging. SOX71 is highly biocompatible, and shows decreased sensitivity to oxygen and self-relaxation. This first report suggests that SOX71 is superior to OX071 for absolute oxygen mapping under a broad range of pO2 values.